v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 298,503 $ 291,385
Accounts receivable, net 1,175,341 46,843
Other current receivables and prepayments 0 2,088
Total Current Assets 1,473,844 340,316
Non-Current Assets    
Intangible assets, net 108,079 128,710
Total Non-Current Assets 108,079 128,710
Total Assets 1,581,923 469,026
Current Liabilities    
Accounts payable and accrued expenses 54,991 38,737
Accrued liabilities-related party 0 16,289
Bank overdraft 0 16,109
Due to related parties 352,984 360,640
Taxes payable 54,881 0
Total Current Liabilities 462,856 431,775
Non-Current Liabilities 0 0
Total Liabilities 462,856 431,775
Commitments and Contingencies
Shareholders’ Equity    
Series B Preferred stock, par value $0.001 per share; 118,000,000 shares authorized; 0 and 117,318,448 shares issued and outstanding at December 31, 2025 and December 31, 2024 0 117,318
Common Stock, par value $0.001 per share; 40,000,000,000 shares authorized; 20,194,429,021 and 2,596,661,821 shares issued and outstanding at December 31, 2025 and December 31, 2024 20,194,429 2,596,662
Additional paid-in capital (16,668,801) 811,648
Accumulated loss (2,405,184) (3,464,472)
Accumulated other comprehensive loss (1,377) (23,905)
Total Shareholders’ Equity 1,119,067 37,251
Total Liabilities and Shareholders’ Equity $ 1,581,923 $ 469,026